Production of immunoreactive polymorphonuclear leucocyte elastase in human breast cancer cells: possible role of polymorphonuclear leucocyte elastase in the progression of human breast cancer.

[1]  Plasminogen activator , 2020, Definitions.

[2]  M. Ogawa,et al.  Industrial preparation of poly(vinyl chloride). , 1975, British Journal of Cancer.

[3]  M. Ogawa,et al.  Breast cancer prognosis is poor when total plasminogen activator activity is low. , 1993, British Journal of Cancer.

[4]  M. Ogawa,et al.  Hormone control of total plasminogen activator activity is specific to malignant DMBA-induced rat mammary tumours. , 1992, British Journal of Cancer.

[5]  L. Ossowski,et al.  Estradiol modulation of plasminogen activator production in organ cultures of human breast carcinomas: Correlation with clinical outcome of anti‐estrogen therapy , 1991, International journal of cancer.

[6]  C. Wu,et al.  Cell associated elastase activities of rat mammary tumour cells. , 1990, Biochemistry international.

[7]  K. Ulm,et al.  Urokinase-type plasminogen activator (u-PA) antigen is a predictor of early relapse in breast cancer , 1990 .

[8]  W. McGuire,et al.  Cathepsin D and prognosis in breast cancer. , 1990, The New England journal of medicine.

[9]  W. Owen,et al.  An elastase-dependent pathway of plasminogen activation. , 1989, Biochemistry.

[10]  M. Duffy,et al.  Urokinase‐plasminogen activator, a marker for aggressive breast carcinomas. Preliminary report , 1988, Cancer.

[11]  Y. Iwamoto,et al.  Effects of inhibitors of plasminogen activator, serine proteinases, and collagenase IV on the invasion of basement membranes by metastatic cells. , 1988, Cancer research.

[12]  M. Duffy.  Do proteases play a role in cancer invasion and metastasis? , 1987, European journal of cancer & clinical oncology.

[13]  M. Zeydel,et al.  Collagenase and elastase production by mouse mammary adenocarcinoma primary cultures and cloned cells. , 1986, Cancer research.

[14]  D. Rifkin,et al.  Tumor invasion through the human amniotic membrane: Requirement for a proteinase cascade , 1986, Cell.

[15]  J. Cajot,et al.  Plasminogen activators, plasminogen activator inhibitors and procoagulant analyzed in twenty human tumor cell lines , 1986, International journal of cancer.

[16]  L. Ostrowski,et al.  Inhibition of proteolytic enzymes in the in vitro amnion model for basement membrane invasion. , 1986, Cancer research.

[17]  S. Horiuchi,et al.  Plasminogen activator as a functional marker for estrogen dependence in human breast cancer cells. , 1986, Japanese journal of cancer research : Gann.

[18]  L. Liotta,et al.  Expression of collagenase IV (basement membrane collagenase) activity in murine tumor cell hybrids that differ in metastatic potential. , 1985, Journal of the National Cancer Institute.

[19]  S. Horiuchi,et al.  Estrogen-dependent plasminogen activator in 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors in vivo and in vitro. , 1984, Gan.

[20]  R. Stern,et al.  Elastin degradation by proteases from cultured human breast cancer cells. , 1982, Biochemical and biophysical research communications.

[21]  J. McDonald,et al.  Degradation of fibronectin by human leukocyte elastase. Release of biologically active fragments. , 1980, The Journal of biological chemistry.

[22]  A. Kang,et al.  Degradation of type IV (basement membrane) collagen by a proteinase isolated from human polymorphonuclear leukocyte granules. , 1980, The Journal of biological chemistry.

[23]  L. Liotta,et al.  Activation of human breast carcinoma collagenase through plasminogen activator. , 1980, Life sciences.

[24]  A. Recklies,et al.  Secretion of proteinases from malignant and nonmalignant human breast tissue. , 1980, Cancer research.

[25]  W. Hornebeck,et al.  Elastogenesis and elastinolytic activity in human breast cancer. , 1977, Biomedicine / [publiee pour l'A.A.I.C.I.G.].

[26]  J. Travis,et al.  Human leukocyte granule elastase: rapid isolation and characterization. , 1976, Biochemistry.

[27]  K. Pavelić,et al.  [Histological classification of breast tumors]. , 1975, Lijecnicki vjesnik.

[28]  N. Mantel.  Evaluation of survival data and two new rank order statistics arising in its consideration. , 1966, Cancer chemotherapy reports.

[29]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[30]  I. Banga,et al.  Elastase and Elastase-Inhibitor , 1949, Nature.

[31]  M. Ogawa,et al.  Demonstration of a possible link between high grade malignancy in dimethylbenz[a]anthracene-induced rat mammary carcinoma and increased urokinase plasminogen activator content , 1992, International journal of clinical & laboratory research.

[32]  S. Neumann,et al.  Enzyme-linked immunoassay for human granulocyte elastase in complex with alpha 1-proteinase inhibitor. , 1984, Advances in experimental medicine and biology.

[33]  R. W. Scarff,et al.  Histological typing of breast tumors. , 1982, Tumori.

[34]  D.,et al.  Regression Models and Life-Tables , 2022 .